Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.47 |
| ▸ | HTR3B | O95264 | 1/20 | 0.47 |
| ▸ | HTR3A | P46098 | 1/20 | 0.47 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.47 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.47 |
| ▸ | F2 | P00734 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | BCHE | P06276 | 2/20 | 0.47 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.46 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.44 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.44 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.44 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11061705 | 0.91 | SLC18A3 (0.48) | CHRNA7MEN1KMT2AHTR3EHTR3B | |
| SCHEMBL2573684 | 0.90 | POLB (0.43) | CHRNA7LMNA | |
| SCHEMBL23817377 | 0.90 | SLC18A3 (0.50) | CHRNA7MEN1KMT2AHTR3EHTR3B | |
| SCHEMBL2568781 | 0.87 | KMT2A (0.41) | CHRNA7KMT2ABCHETSHR | |
| SCHEMBL10338863 | 0.85 | BCHE (0.53) | CHRNA7MEN1KMT2AHTR3EHTR3B | |
| SCHEMBL10995636 | 0.83 | BCHE (0.51) | CHRNA7MEN1KMT2AHTR3EHTR3B | |
| SCHEMBL2574276 | 0.83 | KDM4E (0.40) | BCHETSHR | |
| SCHEMBL11245395 | 0.83 | BCHE (0.46) | CHRNA7MEN1KMT2AHTR3EHTR3B | |
| SCHEMBL27544283 | 0.82 | SCN1A (0.54) | MEN1KMT2ALMNAGAA | |
| SCHEMBL1648492 | 0.81 | RAB9A (0.47) | MEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240067776-A1 | METHOD FOR PREPARING POLYETHER CARBONATES | ECONIC TECHNOLOGIES LTD (GB) | 2024-02-29 | — | — | US | disclosed |
| US-20230033621-A1 | A POLYOL BLOCK COPOLYMER | ECONIC TECHNOLOGIES LTD. (GB) | 2023-02-02 | — | — | US | disclosed |
| US-20220185956-A1 | METHOD FOR QUENCHING A POLYMERISATION PROCESS | ECONIC TECHNOLOGIES LTD (GB) | 2022-06-16 | — | — | US | disclosed |
| WO-2021018085-A1 | PREPARATION METHOD FOR HEXAHYDROFUROFURANOL DERIVATIVE, AND INTERMEDIATE OF THE DERIVATIVE AND PREPARATION METHOD THEREFOR | 浙江九洲药业股份有限公司 | 2021-02-04 | — | — | WO | disclosed |
| US-20200369829-A1 | METHOD FOR PREPARING POLYOLS | ECONIC TECHNOLOGIES LTD. (GB) | 2020-11-26 | — | — | US | disclosed |
| US-10774180-B2 | Catalysts | ECONIC TECHNOLOGIES LTD. (GB) | 2020-09-15 | — | — | US | disclosed |
| US-10774179-B2 | Method for preparing polyols | ECONIC TECHNOLOGIES LTD. (GB) | 2020-09-15 | — | — | US | disclosed |
| US-10556988-B2 | Catalysts | ECONIC TECHNOLOGIES LTD (GB) | 2020-02-11 | — | — | US | disclosed |
| US-20190055352-A1 | CATALYSTS | ECONIC TECHNOLOGIES LTD. (GB) | 2019-02-21 | — | — | US | disclosed |
| US-20180148539-A1 | METHOD FOR PREPARING POLYOLS | ECONIC TECHNOLOGIES LTD. (GB) | 2018-05-31 | — | — | US | disclosed |
| US-20170210848-A1 | Catalysts | ECONIC TECHNOLOGIES LTD (GB) | 2017-07-27 | — | — | US | disclosed |
| EP-1466946-B1 | FLAME-RETARDANT RESIN COMPOSITION | POLYPLASTICS CO (JP) | 2011-11-09 | — | — | EP | disclosed |
| EP-1466946-A1 | FLAME-RETARDANT RESIN COMPOSITION | Polyplastics Co., Ltd. (JP) | 2004-10-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10774180-B2 | Catalysts | CA1, CA12, CA4 | CHRNA7 2105/4885MEN1 290/4885KMT2A 2911/4885 |
| US-20190055352-A1 | CATALYSTS | CA1, CA12, CA4 | CHRNA7 2105/4885MEN1 290/4885KMT2A 2911/4885 |
| US-20170210848-A1 | Catalysts | MLX, CA3, CA1 | CHRNA7 919/4885MEN1 2229/4885KMT2A 1627/4885 |
| US-10556988-B2 | Catalysts | MLX, CA3, CA1 | CHRNA7 919/4885MEN1 2229/4885KMT2A 1627/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.